Pharma.Aero’s project IoT Devices and Platforms in Healthcare Logistics was designed to further explore and seek to leverage the use of next-generation IoT devices to improve Life Science & Healthcare Logistics. The white paper presents the outcomes of this cross-industry initiative assessing the maturity, applicability, and strategic value of next-generation IoT technologies across pharmaceutical supply chains.
Read the White Paper here
The project confirms that the industry is moving through a clear transition. IoT technologies are increasingly used across healthcare logistics, but their full potential remains underleveraged. In many cases, IoT data is still used to monitor what happened, rather than to predict and prevent what may happen next.
The white paper highlights that visibility alone does not create value. Value emerges when IoT data is connected to structured decision-making, predictive analytics, and operational action.
Key findings
The report identifies several recurring barriers across the sector:
- fragmented systems and limited interoperability
- inconsistent global connectivity
- gaps in data standardisation
- cybersecurity and compliance concerns
- limited digital skills and change management capacity
At the same time, the project confirms that IoT, when combined with AI, secure connectivity, and structured training, can support the shift from reactive monitoring to predictive supply chain management.
Why this matters
Pharmaceutical logistics is becoming more complex, driven by advanced biologics, vaccines, cell and gene therapies, and personalised medicines. These products require stricter environmental control, stronger traceability, and more resilient global coordination.
The white paper shows that the next phase of digital supply chain visibility is not only about deploying devices. It is about building the data ecosystems, governance structures, and organisational capabilities needed to turn visibility into intelligence.
A collective industry effort
This publication reflects the contribution of Pharma.Aero members, project leads, subject matter experts, and associate partners who supported the research, interviews, surveys, and executive training sessions behind the project.
Together, we continue to advance patient-centric, resilient, and digitally empowered pharmaceutical supply chains.
The more detailed, in-depth Technical Report of this project is available for Pharma.Aero members only, in the Member Area of the website, here.
Not yet a member? Learn more about memberships and benefits.